12 pages, To date, there has been an increase in genome modification biotechnologies that improve production and food security but the process has not been accompanied by the delivery of information about them intended for citizens. This is essential considering that to achieve better health, food security and sustainability these biotechnologies need to be incorporated into production systems. This study aimed to explore perceptions and attitudes of Chilean citizens towards the use of genome modifications with an emphasis on transgenes and genome editing (CRISPR). An electronic questionnaire was applied, and afterwards the results were analysed through descriptive statistics, GLM, Spearman’s correlation and Wilcoxon Signed Rank test. A total of 702 questionnaires were analysed. High awareness of concepts such as transgenic and cloning was reported with CRISPR being the least known term. Most respondents perceived negative effects on health regarding the consumption of genetically modified products, with women having a significantly more negative attitude. Still, a high willingness to use CRISPR for improving animal and human health was reported. When comparing vegetable and animal products that underwent CRISPR or transgenes, the willingness to consume these products was higher for vegetables. The results show that changes in perception can be achieved after providing the definition of CRISPR and transgenic, therefore, consumer education seems to be essential. Science communication focused on making information about genome modification biotechnologies available to citizens could promote more positive attitudes and perceptions and facilitate their future implementation in the country.
Hansen, Maggie Jo (author) and Edgar, Leslie D. (author)
Format:
Paper
Publication Date:
2015
Published:
Belgium
Location:
Agricultural Communications Documentation Center, Funk Library, University of Illinois Box: 138 Document Number: D05787
Notes:
Paper presented in the Agricultural Communications Section of the annual conference of the Southern Association of Agricultural Scientists, Atlanta, Georgia, January 31-February 1, 2015. 23 pages.
9 pages, Humans have improved plants for their utility through selective self-pollination, crossing, and progeny selection for >10,000 years, largely based on physical characteristics. Less than 200 years ago, the genetic basis of heritability in selection was revealed, enabling breeders to accelerate genetic gain. Breakthroughs in genomics and molecular markers for the past century have enabled breeders to locate and select genomic regions affecting desirable traits, improving breeding precision. Transgenesis has enabled crop insertion of desirable exogenous genes, enabling de novo functionality. These technologies, along with agronomic practices, have generated more than sixfold yield improvements in crops such as corn in the past century. Gene editing, with its unique ability to precisely edit, change expression, and move genes within a crop's genome, has the potential to be the next breakthrough technology. For this to come to fruition, it is critical to take a holistic view considering perspectives of scientists, farmers, regulators, and consumers.
26 pages., via online journal., This paper employs the patent data of four major genetically modified (GM) crops, soybeans, cotton, maize and rapeseed, to illustratee how the innovation of GM crop technology diffused and distributed globally over time. Data collected from the Derwent Innovation Index, were employed to construct country patent citation networks, from 1984 to 2015, and the results revealed that developed countries were early adopters, and the primary actors in the innovation of GM crop technology. Only seven developing countries appeared in the country citation network. Most developed countries were reluctant to apply GM crop technology for commercial cultivation. Private businesses stood out in the patent citation network. The early adoption and better performance of developed countries can be explained by the activities of large established private companies.
